Search

Your search keyword '"RECEPTOR for advanced glycation end products (RAGE)"' showing total 284 results

Search Constraints

Start Over You searched for: Descriptor "RECEPTOR for advanced glycation end products (RAGE)" Remove constraint Descriptor: "RECEPTOR for advanced glycation end products (RAGE)" Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
284 results on '"RECEPTOR for advanced glycation end products (RAGE)"'

Search Results

1. Lens capsule advanced glycation end products induce senescence in epithelial cells: Implications for secondary cataracts.

2. Diabetic Microenvironment‐Unlocked BioHJzyme with H2S Evolution for Robust Anti‐Pathogens and Hyperinflammatory Wound Regeneration Through TGF‐β/Smad Pathway.

3. Expression profiles and functional analysis of transfer RNA‐derived small RNAs (tsRNAs) in photoaged human dermal fibroblasts.

4. Increased alpha‐synuclein and neuroinflammation in the substantia nigra triggered by systemic inflammation are reversed by targeted inhibition of the receptor for advanced glycation end products (RAGE).

5. Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease.

6. Advances in the study of S100A9 in cardiovascular diseases.

7. Synergistic Osteogenic and Antiapoptotic Framework Nucleic Acid Complexes Prevent Diabetic Osteoporosis.

8. Hepatic inflammation and fibrosis are profiles related to mid‐term mortality in biopsy‐proven MASLD: A multicenter study in Japan.

9. Direct and acute effects of advanced glycation end products on proteostasis in isolated mouse skeletal muscle.

10. Effects of glycation reactions on the structure and immunological properties of sesame proteins.

11. Oxymatrine attenuates sepsis‐induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF‐κB signaling pathway.

12. Receptor for Advanced Glycation End Product (RAGE) Modulates Inflammation During Feeding of the Hard Tick, Haemaphysalis longicornis in Mice.

13. Mammalian Diaphanous1 signalling in neurovascular complications of diabetes.

14. Human papillomavirus infection affects treatment outcomes and the immune microenvironment in patients with advanced penile squamous cell carcinoma receiving programmed cell death protein 1 inhibitor–based combination therapy.

15. RAGE induces physiological activation of NADPH oxidase in neurons and astrocytes and neuroprotection.

16. An Interfacial‐Assembled Self‐Supporting Nanofilm Induced by Strong Intermolecular Interaction between Silk Fibroin and Lysozyme.

17. Development of Receptor for Advanced Glycation End Products (RAGE) ligands through target directed dynamic combinatorial chemistry: a novel class of possible antagonists.

18. Cationic ribosomal proteins can inhibit pro‐inflammatory action stimulated by LPS+HMGB1 and are hindered by advanced glycation end products.

19. l‐Theanine delays d‐galactose‐induced senescence by regulating the cell cycle and inhibiting apoptosis in rat intestinal cells.

20. Mitochondrial damage and clearance in retinal pigment epithelial cells.

21. Effects of a high‐fat and high‐carbohydrate diet on appetite regulation and central AMPK in the hypothalamus of blunt snout bream (Megalobrama amblycephala).

22. The HMGB1–RAGE axis in nucleus accumbens facilitates cocaine‐induced conditioned place preference via modulating microglial activation.

23. Transient Self‐Assembled Materials with Controllable Lifespan for Programmable Fluorescence.

24. Exploring the comorbidity mechanisms between psoriasis and obesity based on bioinformatics.

25. Atomic tracking of thermally‐driven structural evolution in 2D crystals: Case of NbSe2.

26. Gut microbiota dysbiosis as a novel pathogenic factor of diabetic peripheral neuropathy.

27. Blueberry anthocyanins extract inhibits advanced glycation end‐products (AGEs) production and AGEs‐stimulated inflammation in RAW264.7 cells.

28. Advanced glycated end‐products inhibit dilation through constitutive endothelial RAGE and Nox1/4 in rat isolated skeletal muscle arteries.

29. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments.

30. Neuroprotective potential of formononetin, a naturally occurring isoflavone phytoestrogen.

31. Nonenzymatic glycation as a tunable technique to modify plant proteins: A comprehensive review on reaction process, mechanism, conjugate structure, and functionality.

32. Biomarkers of cellular senescence and risk of death in humans.

33. Real‐world effectiveness and safety of RC48‐ADC alone or in combination with PD‐1 inhibitors for patients with locally advanced or metastatic urothelial carcinoma: A multicenter, retrospective clinical study.

34. Survival benefit and biomarker of PD‐1 inhibitor combination therapy in first‐line of advanced biliary tract cancer: A retrospective study.

35. Effects of HMGB1/RAGE/cathespin B inhibitors on alleviating hippocampal injury by regulating microglial pyroptosis and caspase activation in neonatal hypoxic–ischemic brain damage.

36. Cannabidiol ameliorates inflammatory response partly by AGE‐RAGE pathway in diabetic mice.

37. Effects of sinapic acid on lead acetate‐induced oxidative stress, apoptosis and inflammation in testicular tissue.

38. Hats off to 20S proteasome substrate discovery.

39. Recent Advances in Anti-Atherosclerosis and Potential Therapeutic Targets for Nanomaterial-Derived Drug Formulations.

40. Influence of chrysin on D‐galactose induced‐aging in mice: Up regulation of AMP kinase/liver kinase B1/peroxisome proliferator‐activated receptor‐γ coactivator 1‐α signaling pathway.

41. CircRNA‐406918 enhances the degradation of advanced glycation end products in photoaged human dermal fibroblasts via targeting cathepsin D.

42. Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.

43. Thirty years of fruitful collaborations between a physician and mass spectrometrists in diabetes field.

44. Pharmacological antagonism of receptor for advanced glycation end products signaling promotes thermogenesis, healthful body mass and composition, and metabolism in mice.

45. Dimethyl fumarate‐mediated Nrf2/ARE pathway activation and glibenclamide‐mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes‐associated fatty liver in rats by mitigating oxidative stress and inflammation.

46. Ultrasound‐assisted glycation and the allergenicity of α‐lactalbumin.

47. Released dsDNA‐triggered inflammasomes serve as intestinal radioprotective targets.

48. An efficient combination immunotherapy for antitumor immunity without accelerating cardiac allograft rejection.

49. Glycation‐mediated tissue‐level remodeling of brain meningeal membrane by aging.

50. Emerging therapeutic strategies for enhancing sensitivity and countering resistance to programmed cell death protein 1 or programmed death‐ligand 1 inhibitors in non–small cell lung cancer.

Catalog

Books, media, physical & digital resources